Form 4 for ABT Abbott Laboratories
Accepted 2021-10-27 00:00:00 ET · period of report 2021-10-26 · accession 0001415889-21-004997 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2021-10-27 | 2021-10-26 | ABT | OSBORN WILLIAM A | Dir | M - OptEx | $59.42 | +15.8K | 97.0K | +19% | +$936.0K |
| D | 2021-10-27 | 2021-10-26 | ABT | OSBORN WILLIAM A | Dir | M - OptEx | $0.00 | -15.8K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common shares without par value | 2021-10-26 | M | A | 15,752 | $59.42 | 96,996 | D | — | — | |
| 2 | Derivative | Option (right to buy) | 2021-10-26 | M | D | 15,752 | $0.00 | 0 | D | $59.42 · 2018-04-27 to 2028-04-26 | 15,752 Common Shares | (F1) Stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3. |